Republic of Lebanon
Ministry of Public Health

Communicable Diseases Surveillance

Acute Flaccid Paralysis AFP Surveillance


Table 1a: Reported AFP cases by year

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
N cases 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Epidemiology Surveillance Unit
AFP surveillance

Table 1b: Reported AFP cases by year and mohafaza

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
BEIRUT 2 2 1 0 0 3 4 1 1 1 2 2 6 2 4 3 2 5 8 8
BEKAA 2 3 3 4 2 5 1 1 4 8 1 1 2 0 5 6 10 24 19 13
MOUNT-LEBANON 2 4 6 3 8 4 4 4 4 4 4 2 5 11 8 12 17 35 45 14
NABATIEH 0 1 2 1 0 1 2 0 2 4 1 0 2 3 2 1 4 14 12 6
NORTH 4 2 1 4 2 7 2 5 3 4 4 1 4 4 3 5 12 24 16 10
SOUTH 0 1 0 2 4 0 1 2 1 2 6 2 0 2 2 6 5 11 11 10
Total 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Epidemiology Surveillance Unit
AFP surveillance

Table 2a: AFP surveillance indicators by year

as on 16/09/2017
10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Investigation rate 90.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 93.3% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Investigated within 48 hours of notification 90.0% 84.6% 84.6% 85.7% 100.0% 100.0% 100.0% 100.0% 86.7% 91.3% 94.4% 100.0% 100.0% 90.9% 87.5% 97.0% 98.0% 98.2% 97.3% 98.4%
Reported within 1 week of onset 40.0% 46.2% 76.9% 35.7% 62.5% 80.0% 42.9% 76.9% 40.0% 47.8% 66.7% 62.5% 42.1% 45.5% 33.3% 30.3% 54.0% 75.2% 68.5% 60.7%
With 2 stool specimens 10.0% 30.8% 92.3% 100.0% 100.0% 100.0% 100.0% 92.3% 86.7% 95.7% 94.4% 87.5% 73.7% 72.7% 87.5% 69.7% 92.0% 97.3% 96.4% 86.9%
With 2 adequate stool specimen 10.0% 30.8% 84.6% 57.1% 81.3% 75.0% 78.6% 92.3% 53.3% 65.2% 77.8% 50.0% 47.4% 45.5% 50.0% 45.5% 70.0% 84.1% 82.9% 70.5%
Epidemiology Surveillance Unit
AFP surveillance

Table 3a: Reported AFP cases by year and age group

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Age groups
Under 1 year 0 1 2 0 1 2 1 1 2 2 1 0 1 1 0 2 2 4 5 3
1-4 years 5 5 5 5 3 4 5 3 4 5 7 3 6 5 4 18 17 44 36 23
5-9 years 2 0 4 8 7 10 5 5 3 10 6 3 7 7 15 7 18 39 44 21
10-14 years 3 7 2 1 5 4 3 4 6 6 4 1 5 9 3 6 13 25 25 14
Unspecified 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 1 1 0
TOTAL 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Epidemiology Surveillance Unit
AFP surveillance

Table 3b: Reported AFP cases by clinical data and year

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Fever at onset
1 YES 3 0 3 4 2 4 2 3 1 7 5 0 6 5 5 8 18 63 71 34
2 NO 6 9 10 10 14 16 12 10 14 15 9 8 13 16 15 25 25 40 38 26
UNKNOWN 1 4 0 0 0 0 0 0 0 1 4 0 0 1 4 0 7 10 2 1
Total 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Asymetric paralysis
1 YES 0 1 5 1 4 3 4 0 7 6 3 3 8 3 5 3 12 33 31 19
2 NO 9 8 8 13 12 17 10 13 7 17 14 5 11 19 17 30 34 62 80 41
UNKNOWN 1 4 0 0 0 0 0 0 1 0 1 0 0 0 2 0 4 18 0 1
Total 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Rapid progress with 4 days
1 YES 4 5 4 5 8 15 10 10 10 17 15 7 14 13 14 25 32 55 85 43
2 NO 3 3 2 6 4 5 4 3 3 6 2 1 4 8 8 8 14 28 26 17
UNKNOWN 3 5 7 3 4 0 0 0 2 0 1 0 1 1 2 0 4 30 0 1
Total 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Epidemiology Surveillance Unit
AFP surveillance

Table 3c: Reported AFP cases by year & vaccination status

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Number of OPV/IPV doses received
. 7 1 1 1 1 2 2 1 7 2 3 0 2 1 2 0 3 5 3 0
0 1 0 0 0 0 1 0 0 1 1 1 0 1 0 2 2 0 2 7 2
1 0 0 1 1 0 1 1 1 0 1 2 0 1 2 2 1 1 2 1 0
2 0 0 0 3 2 0 0 0 1 0 0 0 0 1 1 1 7 11 8 4
3 1 3 5 2 4 4 2 1 3 2 1 0 0 5 5 5 7 37 37 18
4 0 3 2 2 2 5 4 5 2 8 3 3 11 9 6 18 11 32 38 22
5 0 5 2 1 3 5 4 3 0 9 7 5 4 3 5 6 17 15 15 12
6 1 1 1 1 0 2 1 2 1 0 0 0 0 1 0 0 2 6 2 1
7 0 0 0 2 3 0 0 0 0 0 1 0 0 0 1 0 2 0 0 2
8 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0
9 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
Total 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Epidemiology Surveillance Unit
AFP surveillance

Table 4a: Reported AFP cases by year & adequate specimen

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
ADEQUATE 1 4 11 8 13 15 11 12 8 15 14 4 9 10 12 15 35 95 92 43
INADEQUATE 9 9 2 6 3 5 3 1 7 8 4 4 10 12 12 18 15 18 19 18
Total 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Rate of adequate specimens 10.0% 30.8% 84.6% 57.1% 81.3% 75.0% 78.6% 92.3% 53.3% 65.2% 77.8% 50.0% 47.4% 45.5% 50.0% 45.5% 70.0% 84.1% 82.9% 70.5%
Epidemiology Surveillance Unit
AFP surveillance

Table 4b: Reported AFP cases by year and stool results

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Wild Poliovirus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wild Poliovirus type 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wild Poliovirus type 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wild Poliovirus type 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Vaccine Poliovirus 1 0 1 0 0 1 0 1 0 1 0 0 1 0 0 2 1 1 4 1
Vaccine Poliovirus type 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 1 0 3 0
Vaccine Poliovirus type 2 1 0 0 0 0 0 0 1 0 0 0 0 1 0 0 2 0 0 0 0
Vaccine Poliovirus type 3 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 2 0 1 3 1
Non polio enterovirus 0 0 0 1 0 0 1 2 0 1 0 0 0 2 2 0 1 4 9 5
Negative 4 9 11 13 16 18 13 9 13 20 17 7 13 15 20 22 45 106 95 48
Pending 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 9 2 2 3 7
No specimen processed 5 4 1 0 0 0 0 1 2 1 1 1 4 5 0 0 1 0 0 0
Total 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Epidemiology Surveillance Unit
AFP surveillance

Table 5: Reported AFP cases by year and follow up

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
DIED 0 0 0 0 0 0 0 0 1 0 0 1 1 1 0 0 1 5 3 2
LOST 0 0 0 0 0 1 0 0 0 1 0 0 1 0 3 3 0 0 2 0
NO RESIDUAL WEAKNESS 5 5 9 11 6 7 7 8 6 9 10 5 9 10 8 29 24 61 74 38
PENDING 0 0 0 0 0 1 1 1 5 5 2 0 2 5 5 0 19 24 2 10
RESIDUAL WEAKNESS 0 2 4 3 10 11 6 4 3 8 6 2 6 6 8 1 6 23 30 11
UNSPECIFIED 5 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Epidemiology Surveillance Unit
AFP surveillance

Table 6a: Reported AFP cases by year & classification

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
COMPATIBLE 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
CONFIRMED 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DISCARDED 10 13 13 14 16 19 14 13 15 23 17 8 19 22 24 33 50 113 111 51
PENDING 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10
Total 10 13 13 14 16 20 14 13 15 23 18 8 19 22 24 33 50 113 111 61
Epidemiology Surveillance Unit
AFP surveillance

Table 6b: Non-polio AFP cases by year & final diagnosis

as on 16/09/2017
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
ACUTE MYOSITIS 0 0 0 0 1 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0
GUILLAIN BARRE 8 11 10 12 12 18 11 9 9 15 14 6 8 12 16 21 25 31 28 11
NON POLIO MYELITIS 0 0 0 1 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0
OTHER 0 1 0 0 2 0 2 0 2 5 3 0 10 10 7 10 22 78 79 39
PENDING 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1
TRANSVERSE MYELITIS 2 0 1 1 1 0 1 1 1 0 0 2 1 0 1 2 1 2 1 0
UNSPECIFIED 0 1 1 0 0 0 0 0 3 1 0 0 0 0 0 0 2 2 0 0
VAPP 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Total 10 13 13 14 16 19 14 13 15 23 17 8 19 22 24 33 50 113 111 51
Epidemiology Surveillance Unit
AFP surveillance